On December 17, 2024, Jeeyar Integrative Medical Services & BBC Cure, USA hosted a one-day International Conference on Oncology, themed “Converging on Cancer Research.” The conference, attended by 250 participants, aimed to share the latest advancements in cancer treatment and research.
The event commenced with an inaugural ceremony, which included the lighting of the lamp by dignitaries and a prayer song by 1st-year BHMS students. Krishnaswamiji emphasized the importance of awareness about cervical cancer and initiatives undertaken by Vikas Tarangini. Dr. Pravas Kumar Pal, Medical Superintendent of JIMS Hospital, presented the hospital’s integrative treatment approach, its history, and the contributions of Chinna Jeeyar Swamiji, Late Dr. Pavaluri Krishna Chaudary, and Dr. Jupally Rameshwar Rao. Srimati Madhavi Ravindra also spoke about Vikas Tarangini’s initiatives for cervical cancer screening.
The conference featured five insightful scientific sessions:
1. Dr. Prashanthi Karyala spoke about exploring cancer mechanisms and therapeutic targets through systems biology approaches, highlighting the importance of understanding disease pathways and potential treatment targets, particularly focusing on breast cancer metastasis.
2. Dr. Shahid Umar discussed the connection between the gut microbiome and cancer, emphasizing the role of microbiome assays and dietary factors in preventing colonic cancer.
3. Dr. Rao Papineni presented on combination therapies in cancer treatment, emphasizing the use of radioluminescence, nanoparticles, and photodynamic therapy for more effective cancer treatments.
4. Dr. Shashi Kiran addressed alternate therapies for HPV-induced cancers, particularly cervical cancer, and explored the molecular mechanisms of HPV-induced carcinogenesis.
5. Dr. Ekta Tripati unveiled the role of CRISPR in regulating DUBs in breast cancer, explaining how gene editing could revolutionize cancer treatment.
The conference successfully brought together medical professionals, researchers, and specialists to explore cutting-edge research and therapies in oncology, contributing to the ongoing fight against cancer.
